These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 4659598

  • 1. [Circulating anticoagulants during hemophilia].
    Josso F, Cosson A, Gazengel C, Allain JP.
    Rev Fr Transfus; 1972 Dec; 15(4):281-98. PubMed ID: 4659598
    [No Abstract] [Full Text] [Related]

  • 2. [Characteristics of the diagnosis, clinical aspects and treatment of hemophilias with specific, circulating anticoagulants].
    Barkagan ZS, Sukhoveeva EIa, Eremin GF, Tolochko OI, Shevchenko VI.
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):35-41. PubMed ID: 4680852
    [No Abstract] [Full Text] [Related]

  • 3. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW, Greene WB, Blatt PM, White GC, Roberts HR.
    Instr Course Lect; 1983 Apr; 32():210-6. PubMed ID: 6443730
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acquired inhibitors of blood coagulation.
    Feinstein DI, Rapaport SI.
    Prog Hemost Thromb; 1972 Apr; 1():75-95. PubMed ID: 4569725
    [No Abstract] [Full Text] [Related]

  • 7. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM, Pourfathollah A, Shooshtari MM, Yazdi ZR.
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Transfusion therapy of hemophilia A and B].
    Egli H.
    Bibl Haematol; 1967 Mar; 27():204-10. PubMed ID: 5595089
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM.
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract] [Full Text] [Related]

  • 12. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L.
    ASDC J Dent Child; 1979 Oct; 46(1):54-6. PubMed ID: 283081
    [No Abstract] [Full Text] [Related]

  • 13. Physiologic considerations in the management of hemophilia.
    Briggs DK.
    Pathobiol Annu; 1971 Oct; 1():205-14. PubMed ID: 4950380
    [No Abstract] [Full Text] [Related]

  • 14. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP, Reesink HW, Mannucci PM, Gringeri A, Ingerslev J, Brettler DB, Mauser-Bunschoten EP, Negrier C, Berntorp E, Smith OP, Shapiro AD.
    Vox Sang; 2000 Oct; 78(4):256-61. PubMed ID: 10970234
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitors in congenital coagulation disorders.
    Key NS.
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [Abstract] [Full Text] [Related]

  • 16. Transfusion support for haemophiliacs.
    Allain JP.
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of hemophilia].
    Stavem P, Hjort PF.
    Tidsskr Nor Laegeforen; 1970 Jul 01; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract] [Full Text] [Related]

  • 20. Problems related to anticoagulants in hemophiliacs.
    Strauss HS.
    Bibl Haematol; 1970 Jul 01; 34():149-53. PubMed ID: 5436341
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.